Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/220088
Title: Retinal structure and its relationship with premorbid, clinical, and cognitive variables in young Spanish patients with early course schizophrenia spectrum disorders
Author: González Díaz, Jairo M.
Sánchez Dalmau, Bernardo
Camós-Carreras, Anna
Alba Arbalat, Salut
Amoretti Guadall, Silvia
Forte, Maria Florencia
Serra Navarro, Maria
Salmerón, Sergi
Pérez Ramos, Anaid
Vieta i Pascual, Eduard, 1963-
Torrent Font, Carla
Bernardo Arroyo, Miquel
Keywords: Esquizofrènia
Malalties mentals
Retina
Tomografia
Psicosi
Schizophrenia
Mental illness
Retina
Tomography
Psychoses
Issue Date: 1-Mar-2025
Publisher: Elsevier B.V.
Abstract: Emerging evidence suggests that retinal structural alterations are present in schizophrenia spectrum disorders (SSD), potentially reflecting broader neurodevelopmental and neurodegenerative processes. This cross-sectional study investigates retinal thickness and its clinical correlations in a sample of early-course SSD patients compared to healthy controls (HCs). One hundred-two eyes from 26 SSD cases and 25 age- and sex-matched HCs were included. Retinal structure was evaluated using Spectral-Domain Optical Coherence Tomography (SD-OCT), focusing on the peripapillary retinal nerve fiber layer (pRNFL), macular volume/thickness, and ganglion cell-inner plexiform layer (GCL+IPL) thickness. Although SSD cases showed increased peripapillary retinal nerve fiber layer (pRNFL) thickness in specific quadrants, most retinal parameters did not differ significantly between groups. Preliminary associations were observed between retinal measures, premorbid adjustment, DUP, and cognitive performance. These findings, while suggesting the potential of retinal imaging as a tool for early detection and monitoring of psychotic disorders, must be interpreted with caution. Further longitudinal and multimodal research is warranted to explore the association between these retinal changes and neuroinflammation, neurodegeneration, and overall brain health in SSD patients.
Note: Versió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2024.12.006
It is part of: European Neuropsychopharmacology, 2025, vol. 92, p. 38-47
URI: https://hdl.handle.net/2445/220088
Related resource: https://doi.org/10.1016/j.euroneuro.2024.12.006
ISSN: 0924-977X
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut de Neurociències (UBNeuro))

Files in This Item:
File Description SizeFormat 
875399.pdf4.3 MBAdobe PDFView/Open    Request a copy


Embargat   Document embargat fins el 28-2-2026


This item is licensed under a Creative Commons License Creative Commons